Literature DB >> 11305910

Contribution of the active site histidine residues of ribonuclease A to nucleic acid binding.

C Park1, L W Schultz, R T Raines.   

Abstract

His12 and His119 are critical for catalysis of RNA cleavage by ribonuclease A (RNase A). Substitution of either residue with an alanine decreases the value of k(cat)/K(M) by more than 10(4)-fold. His12 and His119 are proximal to the scissile phosphoryl group of an RNA substrate in enzyme-substrate complexes. Here, the role of these active site histidines in RNA binding was investigated by monitoring the effect of mutagenesis and pH on the stability of enzyme-nucleic acid complexes. X-ray diffraction analysis of the H12A and H119A variants at a resolution of 1.7 and 1.8 A, respectively, shows that the amino acid substitutions do not perturb the overall structure of the variants. Isothermal titration calorimetric studies on the complexation of wild-type RNase A and the variants with 3'-UMP at pH 6.0 show that His12 and His119 contribute 1.4 and 1.1 kcal/mol to complex stability, respectively. Determination of the stability of the complex of wild-type RNase A and 6-carboxyfluorescein approximately d(AUAA) at varying pHs by fluorescence anisotropy shows that the stability increases by 2.4 kcal/mol as the pH decreases from 8.0 to 4.0. At pH 4.0, replacing His12 with an alanine residue decreases the stability of the complex with 6-carboxyfluorescein approximately d(AUAA) by 2.3 kcal/mol. Together, these structural and thermodynamic data provide the first thorough analysis of the contribution of histidine residues to nucleic acid binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11305910     DOI: 10.1021/bi0100182

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Molecular dynamics simulation of bovine pancreatic ribonuclease A-CpA and transition state-like complexes.

Authors:  Elena Formoso; Jon M Matxain; Xabier Lopez; Darrin M York
Journal:  J Phys Chem B       Date:  2010-06-03       Impact factor: 2.991

Review 2.  Bovine pancreatic ribonuclease: fifty years of the first enzymatic reaction mechanism.

Authors:  Claudi M Cuchillo; M Victòria Nogués; Ronald T Raines
Journal:  Biochemistry       Date:  2011-08-24       Impact factor: 3.162

3.  Ribonuclease S redux.

Authors:  Rex W Watkins; Ulrich Arnold; Ronald T Raines
Journal:  Chem Commun (Camb)       Date:  2010-11-16       Impact factor: 6.222

Review 4.  Integration of kinetic isotope effect analyses to elucidate ribonuclease mechanism.

Authors:  Michael E Harris; Joseph A Piccirilli; Darrin M York
Journal:  Biochim Biophys Acta       Date:  2015-04-30

5.  Recognition of ribonuclease A by 3'-5'-pyrophosphate-linked dinucleotide inhibitors: a molecular dynamics/continuum electrostatics analysis.

Authors:  Savvas Polydoridis; Demetres D Leonidas; Nikos G Oikonomakos; Georgios Archontis
Journal:  Biophys J       Date:  2006-12-01       Impact factor: 4.033

6.  Substrate interactions with human ferrochelatase.

Authors:  Amy Medlock; Larkin Swartz; Tamara A Dailey; Harry A Dailey; William N Lanzilotta
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-29       Impact factor: 11.205

7.  Interpretation of pH-activity profiles for acid-base catalysis from molecular simulations.

Authors:  Thakshila Dissanayake; Jason M Swails; Michael E Harris; Adrian E Roitberg; Darrin M York
Journal:  Biochemistry       Date:  2015-02-06       Impact factor: 3.162

8.  On the information expressed in enzyme primary structure: lessons from Ribonuclease A.

Authors:  Daniel J Graham; Jessica L Greminger
Journal:  Mol Divers       Date:  2009-11-17       Impact factor: 2.943

9.  Structural basis for catalysis by onconase.

Authors:  J Eugene Lee; Euiyoung Bae; Craig A Bingman; George N Phillips; Ronald T Raines
Journal:  J Mol Biol       Date:  2007-10-04       Impact factor: 5.469

10.  Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform.

Authors:  Thomas Schirrmann; André Frenzel; Lars Linden; Beatrix Stelte-Ludwig; Jörg Willuda; Axel Harrenga; Stefan Dübel; Beate Müller-Tiemann; Mark Trautwein
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.